DashboardAll companies
Run this on your own research
Healthcare · Medical Instruments & Supplies

ResMed Inc.

RMDNYSE$252.86−$0.20 (−0.08%)Market closed

Price Chart

Daily

Key facts

Market Cap
$36.59B
P/E
—
P/B
—
ROE
24.3%

ResMed Inc.

Healthcare · Medical Instruments & Supplies · FY 2026

ResMed Inc. is an innovative leader in the development and manufacturing of devices focused on improving the quality of sleep and respiratory health. Operating globally, ResMed specializes in producing advanced equipment for sleep apnea therapy, chronic obstructive pulmonary disease (COPD), and various respiratory conditions. The company's offerings include a range of cutting-edge products like continuous positive airway pressure (CPAP) devices, bilevel systems, and ventilators, designed to enhance patient comfort and compliance. ResMed is also at the forefront of integrating cloud-connected devices to support improved patient monitoring and telemedicine services. The healthcare industry, particularly the medical device sector, benefits significantly from ResMed's contributions, as the company aims to address the growing needs associated with sleep and respiratory conditions. By focusing on both personal and overarching health care solutions, ResMed plays a crucial role in enhancing patient quality of life, thereby solidifying its position as a key player in the global health and respiratory care markets.

CEO
Mr. Michael J. Farrell BE, MBA, SM
Employees
10,600

Company Statistics

Valuation

P/E
—
P/B
—
P/S
—
EV/EBITDA
—
P/FCF
—

Margins

Gross
61.1%
EBITDA
38.5%
Operating
33.8%
Pre-Tax
34.0%
Net
26.9%

Returns

ROA
17.8%
ROE
24.3%
ROIC
22.3%

Growth (CAGR)

Rev 3Yr
10.2%
Rev 5Yr
12.1%
Op Inc 3Yr
18.3%
Net Inc 3Yr
19.3%

Financial Health

Cash & Cash Equivalents
$1.47B
Net Debt
$911.3M
Debt/Equity
36.1%
Interest Cov
—

Profile

Revenue
$5.65B
Shares Out
—
Public markets · Korea, US, Japanalpha-lenz.com · Core by Treasurer
ResMed Inc. (RMD) Stock Forecast 2026 $252.86 — Price, Financials & Analyst Targets | AlphaLenz